SCYNEXIS
SCYX
#10638
Rank
โ‚น2.41 B
Marketcap
โ‚น242.34
Share price
-7.62%
Change (1 day)
364.19%
Change (1 year)

EPS for SCYNEXIS (SCYX)

EPS in 2026 (TTM): -โ‚น470.27

According to SCYNEXIS's latest financial reports the company's current EPS (TTM) is -โ‚น483.76. In 2025 the company made an earnings per share (EPS) of -โ‚น126.52 an increase over its 2024 EPS that were of -โ‚น327.47.

EPS history for SCYNEXIS from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-โ‚น470.27271.7%
2025-โ‚น126.52-61.36%
2024-โ‚น327.47-131.43%
2023โ‚น1,042-195.24%
2022-โ‚น1,09417.6%
2021-โ‚น930.30-75.73%
2020-โ‚น3,833-46.24%
2019-โ‚น7,130242.14%
2018-โ‚น2,084-70.21%
2017-โ‚น6,996-40.51%
2016-โ‚น11,759-41.04%
2015-โ‚น19,946157.69%
2014-โ‚น7,740-96.49%
2013-โ‚น2,20,321307.85%
2012-โ‚น54,020

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Galmed Pharmaceuticals
GLMD
-โ‚น1,198 147.69%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Catalyst Pharmaceuticals
CPRX
โ‚น168.38-134.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Catalent
CTLT
-โ‚น588.88 21.73%๐Ÿ‡บ๐Ÿ‡ธ USA
KemPharm
KMPH
-โ‚น92.10-80.96%๐Ÿ‡บ๐Ÿ‡ธ USA